Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US House clears bill to foster imaging, bioengineering R&D

This article was originally published in Clinica

Executive Summary

A bill to establish a new research institute devoted exclusively to imaging and bioengineering cleared the US House last week by a voice vote. Although both research areas receive some funding from the National Institutes of Health, the work is not co-ordinated and is outside the sphere of molecular biology that that occupies the current institutes, supporters of HR 1795, the National Institute of Biomedical Imaging and Bioengineering Establishment Act, said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074752

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel